Skip to content

project

CARE study

Phase I clinical trial of glypican-3-directed CAR T cells co-expressing interleukin-15 and interleukin-21 in patients with liver cancer.

Known aliases

  • CARE trial

Relationships

No evidence-backed relationships are recorded.

Current clusters